APOTEX INC. v. PFIZER CANADA INC. ET AL
Summary of A-288-17
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Appeal (S.27 - Final) - Others
Detected Type: Appeal (S.27 - Final) - Others [from T-402-16 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| APOTEX INC | GOODMANS LLP | RADOMSKI, HARRY |
| MINISTER OF HEALTH (THE) | ||
| PFIZER CANADA INC | ||
| WYETH LLC |
| Name | Number |
|---|---|
| 668 PATENT | 2436668 |
Patented Medicine: Desvenlafaxine (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Apotex Inc. v. Pfizer Canada Inc. 2019 FCA 16 | Jan 25, 2019 | On August 22, 2017, following proceedings under the Patented Medicines (Notice of Compliance) Regulations, Brown J. of the Federal Court issued an order as part of his judgment (2017 FC 774) prohibiting the Minister of Health from issuing a (NOC to Apotex in respect of a NOA sent by Apotex to Pfizer until the expiry of Canadian Patent No. 2,436,668. The ‘668 Patent concerns a drug called O-desmethyl-venlafaxine (ODV). It is used for the treatment of depression. This appeal relates to Form I ODV succinate which is a particular crystal form of a particular salt of ODV, namely ODV succinate. Apotex appeals the Federal Court Judge’s decision. This appeal, along with the companion appeal in Teva Canada Ltd. v. Pfizer Canada Inc. et al. (2019 FCA 15), concern issues related to the Federal Court Judge’s obviousness analysis in respect of the ‘668 Patent. ... In essence, Apotex argues that the Federal Court Judge misconstrued and misapplied the test for obviousness as set out in Apotex Inc. v. Sanofi-Synthelabo Canada Inc., 2008 SCC 61 and that his obviousness analysis is directly contrary to two judgments rendered by our Court: Bristol-Myers Squibb Canada Co. v. Teva Canada Limited, 2017 FCA 76 [Atazanavir]; and Pfizer Limited v. Ratiopharm Inc., 2010 FCA 204 [Amlodipine]. Apotex also argues that the Federal Court Judge made palpable and overriding errors in considering the properties in his reasons because they are not part of the inventive concept and further erred in including certain elements of the invention story such as the work that occurred prior to the salt screen and after Wyeth first discovered Form I ODV succinate. Apotex also contends that the Federal Court Judge erred in law by rejecting its evidence on anticipation and concluding that its allegations of anticipation were not justified. For the reasons below, I would dismiss the appeal with costs. |
This is an appeal from 2017 FC 774 in T-402-16. [Determination of the appeal is based on automated analysis and should not be relied upon.]
Docket Summary (Google Translate to English)
(32) 2019-02-01 - OttawaTraduction certifiée conforme en français des motifs publics du jugement rendu(e)(s) le 25-JAN-2019 déposée le 01-FEV-2019
Traduction certifiée conforme en français du jugement / doc. # 29 rendu(e)(s) le 25-JAN-2019 déposée le 21-FEV-2019 inscrit(e) dans le livre J. & O., volume 305 page(s) 241 - 241
Memorandum to file from the Registry of the FCA dated 11-FEB-2019 transmitting a copy of the Judgment and Reasons for Judgment to Justice Brown and the Applications section of the FC. placed on file.
Acknowledgment of Receipt received from all parties (by email and fax) with respect to the public Reasons for Judgment dated January 25, 2019 placed on file on 07-FEB-2019
Reasons for Judgment (Public version) rendered by the Honourable Mr. Justice Boivin concurred in by The Honourable Mr. Justice Webb The Honourable Mr. Justice de Montigny dated 25-JAN-2019 The Court's decision is with regard to Appeal received on 01-FEB-2019
Letter from the respondent (Pfizer Canada Inc. and Wyeth LLC) dated 31-JAN-2019 "...The corporate parties do not assert any confidentiality in the reasons and as such they may be publicly released without any redactions." received on 31-JAN-2019
Memorandum to file from the FCA Registry dated 30-JAN-2019 On Friday, January 25, 2019, the Registry inadvertently sent the confidential Reasons for Judgment in files A-283-17 and A-288-17 to all parties in both appeals. Thereafter, the Registry contacted counsel for the appellants in both files; they confirmed that copies of the Reasons for Judgment not related to their own proceeding would be destroyed and that the contents thereof would not be disclosed. placed on file.
Reasons for Judment (Confidential) rendered by The Honourable Mr. Justice Boivin concurred in by The Honourable Mr. Justice Webb The Honourable Mr. Justice de Montigny dated 25-JAN-2019 The Court's decision is with regard to Appeal Filed on 25-JAN-2019
Judgment dated 25-JAN-2019 rendered by The Honourable Mr. Justice Webb The Honourable Mr. Justice Boivin The Honourable Mr. Justice de Montigny Matter considered with personal appearance The Court's decision is with regard to Appeal Result: dismissed Filed on 25-JAN-2019 entered in J. & O. Book, volume 305 page(s) 65 - 65 (Final decision)
****** CANCELLED ****** Sealed envelope pursuant to the Order of the Court dated 18-APR-2016 on behalf of the Court (Webb, Boivin and de Montigny JJ.A.) purporting to contain the Confidential Judgment and Reasons for Judgment Filed on 25-JAN-2019
This matter comes on for hearing on 20-NOV-2018 at Ottawa before The Honourable Mr. Justice Webb The Honourable Mr. Justice Boivin The Honourable Mr. Justice de Montigny Appearances: Mr. Andrew Brodkin and Mr. Richard Naiberg for the appellant Mr. Andrew Shaughnessy, Mr. Andrew Bernstein, Ms. Nicole Mantini and Ms. Rachel Saab for the respondent Language of Hearing: E Court Usher: J. Charlebois Duration: on 20-NOV-2018 from 09:30 to 04:07 Courtroom : West Courtroom - Supreme Court of Canada Court Registrar Candice de Montigny-Williams Total duration: 6:30 Before the Court: appeal Result: reserved Documents filed at hearing: 25 26 27 Appellant's Compendium, Respondents' Compendium and Respondent's Supp. Auth. Comments: docs. 25 to 27 were distributed to the panel during the hearing. Minutes of Hearing entered in Vol. 228 page(s) 211 - 223 Abstract of Hearing placed on file
Supplementary Book of Authorities consisting of 1 volume(s) prepared by the respondent filed at hearing on 20-NOV-2018 3 judges' copies distributed to the panel at the hearing
Compendium (Confidential) consisting of 4 volume(s) prepared by the respondent filed at hearing on 20-NOV-2018 3 judges' copies distributed to the panel at the hearing
Compendium consisting of 2 volume(s) prepared by the appellant filed at hearing on 20-NOV-2018 3 judges' copies distributed to the panel during the hearing
Covering letter from Appellant dated 19-NOV-2018 concerning wishes to refer to a descison rendered by Justice Shore (attached)at the Hearing of November 20, 2018 placed on file on 19-NOV-2018
Affidavit of Tanya Cabral on behalf of the appellant sworn on 19-OCT-2018 confirming service of Doc. No. 23 on Respodents by courier on 19-OCT-2018 filed on 19-OCT-2018
Joint Book of Authorities consisting of 3 volume(s) on behalf of all parties Filed on 19-OCT-2018 5 copy(ies) for the Court (original and judges' copies sent to Ottawa, duplicate retained in Toronto)
Acknowledgements of receipt of an electronic copy of the hearing date order, e-mailed to: Mr. Brodkin (solicitor for Apotex Inc.), to Ms. Mantini (solicitor for Pfizer Canada Inc. and Wyeth LLC) and to Mr. Teza Lwin, solicitor for the Minister of Health placed on file on 10-OCT-2018
Order (time and place) dated 03-OCT-2018 rendered by D. Lanteigne, Judicial Administrator and signed by Judicial Administrator fixing Appeal to be heard at Special Sitting in Ottawa on 20-NOV-2018 to begin at 09:30 Filed on 03-OCT-2018 cc's sent to parties entered in J. & O. Book, volume 304 page(s) 5 - 5 Transmittal letters placed on file
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of doc 20 upon Appellant by courier on 04-SEP-2018 filed on 04-SEP-2018
Public Version of Memorandum of Fact and Law on behalf of the respondent filed on 04-SEP-2018 3 judges' copies stored in Ottawa
Solicitor's certificate of service on behalf of Richard Naiberg confirming service of Doc#18 upon Respondents by process server on 04-SEP-2018 filed on 04-SEP-2018
PUBLIC Memorandum of Fact and Law (further to the directions of the Court) on behalf of the appellant filed on 04-SEP-2018 3 judges' copies stored in Ottawa
Communication from Registry to Judicial Administrator dated 27-AUG-2018 re: fix the hearing date.
Acknowledgment of Receipt received from Mr. Brodkin (fax), Mr. Lwin (email) and Ms. Mantini (fax) with respect to the Direction of the Court dated August 23, 2018, placed on file on 27-AUG-2018
Written directions of the Court: The Honourable Madam Justice Dawson dated 23-AUG-2018 directing "The appellant and the respondent are directed to serve and file redacted, public versions of their memorandum of fact and law within 10 days of the date of this direction." received on 24-AUG-2018 Confirmed in writing to the party(ies)
Communication from Registry to Judicial Administrator dated 22-AUG-2018 re: letter requesting copies of confidential docs (id 41).
Letter from counsel for Teva Canada Limited (not a party in this file). dated 14-AUG-2018 Writing to request public copies of the parties' memoranda of fact and law as only sealed Memoranda have been filed. "...we request that the parties in the Apotex appeal be required to file public versions of the Memoranda." received on 14-AUG-2018
Notice of change of address on behalf of Respondent - Minister of Health received on 17-MAY-2018
Letter from the respondent dated 08-MAY-2018 enclosing a CD containing requested documents. received on 09-MAY-2018
Letter from the appellant dated 08-MAY-2018 enclosing a CD containing requested documents received on 09-MAY-2018
Communication from Registry to Judicial Administrator dated 27-APR-2018 re: fixing date and place for hearing
Affidavit of Lisa Ebdon on behalf of the appellant sworn on 23-APR-2018 confirming service of doc 16 on the respondent by telecopier on 23-APR-2018 filed on 23-APR-2018
Requisition for hearing - Appeal from Appellant filed on 23-APR-2018
Letter from Pfizer Canada Inc. and Wyeth LLC dated 12-APR-2018 regarding the scheduling of the hearing in A-288-17 and A-283-17 - scanned to JA - received on 12-APR-2018
Covering letter from Respondents, Pfizer Canada Inc. and Wyeth LLC dated 03-APR-2018 concerning Doc. Nos. 14 15 placed on file on 03-APR-2018
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Doc. No. 14 upon all parties by courier on 03-APR-2018 filed on 03-APR-2018
Sealed envelope pursuant to Order of the Court rendered 18-APR-2016 on behalf of Respondents, Pfizer Canada Inc. and Wyeth LLC purporting to contain Memorandum of Fact and Law (5 copies; 3 judges' copies & 1 original for OTT) Filed on 03-APR-2018
Letter from APOTEX Inc. dated 27-FEB-2018 The memorandum of fact and law contains confidential references to the appea appeal book filed and should have been marked and filed as confidential. Apotex requests that the Court accept the enclosed envelopes. (Envelopes sent to Ottawa) received on 27-FEB-2018
Acknowledgment of Receipt received from all parties (by email) with respect to the Direction of the Court dated February 23, 2018 placed on file on 26-FEB-2018
Affidavit of Alvin Garcia on behalf of the appellant sworn on 09-FEB-2018 confirming service of the Appellant's Memorandum of Fact and Law on Respondents by personal service on 09-FEB-2018 filed on 09-FEB-2018
Memorandum of fact and law on behalf of the appellant filed on 09-FEB-2018 with proof of service on the Respondent (Minister of Health) 3 judges' copies stored in Ottawa
Written directions of the Court: The Honourable Madam Justice Gleason dated 23-FEB-2018 directing " Apotex Inc.'s Memorandum of Fact and Law, delivered to the Court on February 9, 2018, should be accepted for filing and the respondents may file their Memorandum of Fact and Law within 52 days after February 9, 2018." received on 23-FEB-2018
Communication from Registry to Judicial Administrator dated 21-FEB-2018 re: letter ID 24
Letter from the appellant dated 15-FEB-2018 seeking directions for the filing of their Memorandum of Fact and Law - received on 15-FEB-2018
Memorandum to file from Toronto Local Office dated 16-FEB-2018 The Appellant submitted their Memorandum of Fact and Law along with a cover letter, seeking direction for its filing further to the letter dated 2-FEB-2018. The material has been sent to Ottawa for Court direction. placed on file.
Letter from the appellant dated 02-FEB-2018 seeking direction for an extension of time, to Feb 9, for Apotex to file its Memo of fact and law. [[scanned to FCA-OTT]] received on 02-FEB-2018 with proof of service on the respondent
Affidavit of Lisa Ebdon on behalf of the appellant sworn on 01-DEC-2017 confirming service of Doc. No. 10 on Respondents by courier on 01-DEC-2017 with attached exhibit(s) "A" filed on 01-DEC-2017
Appeal Book consisting of 2 volume(s) prepared by the Appellant with CONFIDENTIAL Tabs 3 & 8, filed on 01-DEC-2017 3 judges' copies stored in Ottawa
Acknowledgment of Receipt received from all parties (by email) with respect to the Direction of the Court (Stratas J.A.) dated November 27, 2017 placed on file on 28-NOV-2017
Written directions of the Court: The Honourable Mr. Justice Stratas dated 27-NOV-2017 directing " ... Documents 9-55, may be filed electronically on a USB key enclosed in a separate confidential envelope; much, if not all of the material, appears to be confidential. The remainder should be filed in paper form within one or more volumes of the appeal book. Given the preference of members of the Court for key documents to be in paper form, the parties are directed to file paper compendia of key documents they will refer to in oral arguments three weeks before the hearing. "Day books" containing other documents may be filed on the day of the hearing." received on 27-NOV-2017
Communication from Registry to Judicial Administrator dated 23-NOV-2017 re: for direction regarding letter from the appellant dated November 23, 2017
Letter from the appellant dated 23-NOV-2017 requesting leave to file the application record and hearing transcripts electronically within the appeal book received on 23-NOV-2017
Acknowledgment of Receipt received from all parties (by email) with respect to the Direction of the Court dated November 21, 2017 placed on file on 22-NOV-2017
Written directions of the Court: The Honourable Mr. Justice Stratas dated 21-NOV-2017 directing " Both the law clerk employed by counsel for the appellant and the registry office refer to an "application record and hearing transcripts" and ask that they be filed electronically. Before the Court is an appeal. The Registry shall confirm that what is being sought concerns an appeal book. Upon confirmation the file may be returned to me for disposition." received on 21-NOV-2017
Communication from Registry to Judicial Administrator dated 15-NOV-2017 re: forwarding the Appellant's letter dated November 1, 2017 for the Court's consideration.
Memorandum to file from John Gornick - Toronto Registry dated 02-NOV-2017 sent letter under green memo seeking directions for the Appellant to file its application record and hearing transcripts electronically. placed on file.
Letter from the appellant dated 01-NOV-2017 requesting to be permitted to file copies of the Application Record electronically on a USB key instead of reproducing same in a paper format. received on 01-NOV-2017
Affidavit of Lisa Ebdon on behalf of the appellant sworn on 01-NOV-2017 confirming service of Doc. # 8 - Agreement to Contents of Appeal Book on Respondents by telecopier on 01-NOV-2017 filed on 01-NOV-2017
Agreement as to the content of the Appeal book from the appellant and all Respondents filed on 01-NOV-2017
Memorandum to file from the Registry of the FCA dated 06-OCT-2017 transmitting a copy of the Notice of Appeal to Justice Brown and the Applications section of the FC. placed on file.
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Doc#6 Notice of Appearance upon Appellant and Respondent (the Minister of Health) by telecopier on 05-OCT-2017 filed on 05-OCT-2017
Notice of appearance on behalf of Respondents (Pfizer Canada Inc. and Wyeth LLC) filed on 05-OCT-2017
Affidavit of Lisa Ebdon on behalf of the appellant sworn on 04-OCT-2017 confirming service of doc.1 on respondents,Pfizer Canaada,Wyeht LLC and Minister of Health by telecopier on 02-OCT-2017 filed on 04-OCT-2017
Copy of doc. 1 with proof of service on Respondent- MOH on 03-OCT-2017 filed on 03-OCT-2017
Affidavit of James Adeney on behalf of The Respondent - The Minister of Health sworn on 03-OCT-2017 confirming service of Doc. # 2 on the appellant Respondents - Pfizer Canada Inc. and Wyeth LLC by telecopier on 03-OCT-2017 with attached exhibit(s) A filed on 03-OCT-2017
Notice of appearance on behalf of The Respondent - The Minister of Health filed on 03-OCT-2017
Notice of Appeal and 2 copies filed on 02-OCT-2017 against a decision of Brown J. dated 22-AUG-2017 (T-402-16) Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: